Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
On Corepath Vs BIO.
My take is that Corepath are still responsible for the testing etc etc. But they was never paying for it. An accredited lab is needed as part of the process to test the entire spectrum of kit needed that will make up the approved FDA marked test.
BIO are paying for the facilitation of this and then marketing it.
We're also assuming that they was involved more than what we got told.
I think the long anticipation added to that.
It's also a bit safer as we aren't then having all the eggs in one basket with Bio-Techne doing everything for us. This could have led to a very low ball buyout. Something we shouldn't want.
Let the company grow significantly before that.
Importantly it's now no costs to us for set up.
Slightly less royalty but it's cashflow. If the test flies, the cashflow grows with the stake in "BIO" with us also benefitting from improvements made to the test along the way.
It's a good first step.
Good post Hogbog 👏
I think what we need is a better understanding of the steps required to get this to market, and understanding of our relationships with the likes of Fair journey, Biotechne and Proteogenix.
A simple process map with a big finger pointing at where we are, to keep it simple wouldn't go a miss.
Good PR would be addressing yesterday's video or simply wouldn't have let it go out.
Not so much the placing but the differences in what was said in the video Vs previous RNS and other hints paint a murky picture.
Sentiment carries a high value at this end of the market and it isnt understood by those running things.
Get new PR, keep investors engaged.
Happy to even do this through the telegram group.
I just got a WhatsApp with a lol emoji on and a screenshot...
There's an obvious clue as to my age with the numbers in my user name... Hint: I'm not 86.
As for cancel culture, as said before, if you had been unlucky enough to follow me on socials, you'll know a bit more about me and my personal views. And you aren't being cancelled, I'm opting not to see a constant stream of ad hominem. Such is the case it is now being directed at someone else. Everyone else can see your posts still 👍.
Good points raised by VV. The company should answer to that. What's changed should be a simple question to answer, if anything. The directors talk interview was garbage as the person asking the questions knew nothing about the company. They did no homework.
Fwiw, the board is full of assumptions and expectations, from me included. We all have them. I'll post again, everyone should be able to freely choose their fors and againsts as well as set their targets.
If someone asks me for a view, I'll return one. I'll not try to be a director of your emotions. That in itself is the reason why I have remained quiet today.
I recall seeing somewhere an initial price target in the US of $450 per test. This lowered to $250. Cannot recall where I saw it. Galleri test is $949 fyi. There is a website called walkinlab that has other tests ranging from 45-300. Didn't investigate how accurate. Just glancing.
China is obviously a different market and supply chain.
We shouldn't compare the two.
I'd prefer not to have one until a much later stage whereby you have a company developed and making revenue with something healthy that will continue to grow and have a direct link/application to purchase this entity so that it isn't forgotten about. But until then, a Nasdaq listing wouldn't suit.
Fwiw my own targets are based off a market slice for wherever that market will be.
It's valuation that's important. Some strangely only go off one years revs.... Bio tech usually goes off 10.
🧐 - be wary of those trying to influence. Everyone's decision should be their own and that's all I've ever promoted.